Damora Therapeutics, Inc. (DMRA)
↓ Download CSVKey ratios (FY2025)
-87.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$210.87M | -$22.26M | -$39.91M | -$61.21M | -$52.23M | -$33.64M | $38.97M | — |
| Net Income | -$209.84M | -$21.44M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M | — |
| EPS (Diluted) | $3.98 | $-18.53 | $-36.08 | $-2.43 | $-2.05 | — | — | — |
| Total Assets | $260.53M | $17.13M | $38.23M | $73.19M | $122.22M | $171.60M | $56.61M | — |
| Total Liabilities | $20.15M | $1.30M | $5.90M | $11.44M | $4.99M | $6.11M | $8.14M | — |
| Shareholders' Equity | $240.38M | $15.83M | $32.33M | $61.75M | $117.22M | $165.49M | -$71.15M | -$33.84M |
| Cash & Equivalents | $257.62M | $14.18M | $21.46M | $32.79M | $62.56M | $163.58M | $11.29M | — |
| Operating Cash Flow | -$6.73M | -$18.62M | -$36.91M | -$42.93M | -$52.31M | -$38.20M | -$19.33M | — |
| Capital Expenditures | — | — | — | $196.0K | $223.0K | — | — | — |
| Shares Outstanding | 1.60M | 1.32M | 1.08M | 25.65M | 25.26M | 25.26M | 260.0K | — |
| Dividends Per Share | $0.00 | $0.00 | — | — | $0.00 | $0.00 | — | — |